TC Biopharm (Holdings) Plc
TCBPY
$0.4898
$0.219881.41%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.51M | -4.21M | -3.89M | -3.96M | 1.24M |
| Total Depreciation and Amortization | 152.10K | 161.10K | 235.90K | 240.40K | 200.90K |
| Total Amortization of Deferred Charges | -- | -- | 1.80K | 1.90K | -- |
| Total Other Non-Cash Items | 156.50K | 980.30K | 732.00K | 746.10K | -5.78M |
| Change in Net Operating Assets | -1.25M | 16.70K | 438.50K | 446.90K | -597.50K |
| Cash from Operations | -3.45M | -3.05M | -2.48M | -2.53M | -4.93M |
| Capital Expenditure | -26.30K | -- | 30.10K | 30.70K | -48.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.60K | -7.10K | -25.10K | -25.60K | -41.20K |
| Cash from Investing | -37.90K | -7.10K | 5.00K | 5.10K | -89.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 89.10K | 89.10K | -- |
| Issuance of Common Stock | 2.79M | 1.01M | 1.87M | 1.87M | 2.20K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -74.00K | 298.80K | 298.80K | 219.80K |
| Cash from Financing | 3.51M | 1.18M | 2.81M | 2.86M | 278.00K |
| Foreign Exchange rate Adjustments | -- | -- | 4.30K | 4.40K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.50K | -1.88M | 337.90K | 344.40K | -4.74M |